U.S. FDA Approves “Artificial Pancreas” for Diabetes Treatment

The U.S. Food and Drug Administration on Wednesday approved Medtronic Plc’s “artificial pancreas” designed to automatically deliver the right dose of insulin to patients with type 1 diabetes.

Read more in scientificamerican.com

Leave a Reply

Your email address will not be published. Required fields are marked *